MSB 7.63% $1.34 mesoblast limited

News: MSB Mesoblast Says US FDA Accepts BLA Resubmission For Remestemcel-L

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 23 (Reuters) - Mesoblast Ltd (MSB) :

    • US FDA ACCEPTS MESOBLAST'S BLA RESUBMISSION FOR REMESTEMCEL-L

    (([email protected];))

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.